The baboon as a non-human primate model of human schistosome infection

Parasitology Today

Volumn 15, Issue 12, 1999, Pages 478-482

  Nyindo, M ^a   Farah, I O ^b  

^a KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^b INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; PRAZIQUANTEL;

ANIMAL MODEL; ANIMAL TISSUE; BABOON; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE PREDISPOSITION; FECES ANALYSIS; GRANULOMA; HELPER CELL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNIZATION; IMMUNOPATHOLOGY; LIVER FIBROSIS; MOUSE; NONHUMAN; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPECIES DIFFERENCE;

ANIMAL WELFARE; ANIMALS; ANTIGENS, PROTOZOAN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HUMANS; LIVER; MICE; MONKEY DISEASES; PAPIO; PARASITE EGG COUNT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

MURINAE; PAPIO; PAPIO HAMADRYAS; PRIMATES; SCHISTOSOMA; SCHISTOSOMIASIS MANSONI;

EID: 0033485320     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01569-0     Document Type: Review

References (48)

1. WHO Fact Sheet on Schistosomiasis, May 1996. 1996;WHO.
2. Sturrock R.F. A review of the use of primates in studying human schistosomiasis. J. Med. Primatol. 15:1986;267-279.
3. Damian R.T.et al. Further development of the baboon as a model for acute schistosomiasis. Mem. Inst. Oswaldo Cruz. 87:1992;261-269.
4. Russell W.M.S., Burch R.L. The principles of humane experimental technique; the three Rs and biomedical research: editorial. Science. 272:1959;1996.
5. Nelson G.S. Schistosome infections as zoonoses in Africa. Trans. R. Soc. Trop. Med. Hyg. 54:1960;301-316.
6. Fenwick A. Baboons as reservoir hosts of Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 63:1969;557-567.
7. Farah I.O.et al. Schistosoma mansoni: development and modulation of the granuloma after single or multiple exposures in the baboon (Papio cynocephalus anubis). Exp. Parasitol. 86:1997;93-101.
8. Yole D.S.et al. Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by irradiated cercaria vaccine. Parasitology. 112:1996;37-46.
9. Muller-Graf C.D.M.et al. Schistosoma mansoni infection in a natural population of olive baboons (Papio cynocephalus anubis) in Gombe Stream National Park, Tanzania. Parasitology. 15:1997;621-627.
10. Fulford A.J.C.et al. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today. 14:1997;23-26.
11. Sturrock R.F., Cottrell B.J., Kimani R. Observations on the ability of repeated light exposures to Schistosoma mansoni cercariae to induce resistance to re-infection in Kenyan baboons (Papio anubis). Parasitology. 88:1984;505-511.
12. Damian R.T., Chapman R.W. The fecundity of Schistosoma mansoni in baboons, with evidence of sex ratio effect. J. Parasitol. 69:1983;987-989.
13. Cheever A. A quantitative post-mortem study of schistosomiasis mansoni in man. Am. J. Trop. Med. Hyg. 17:1968;38-64.
14. Warren K.S., DeWitt W.B. Production of portal hypertension and esophageal varices in the mouse. Proc. Soc. Exp. Biol. Med. 98:1958;99-101.
15. Andrade Z.A. Pathology of human schistosomiasis. Mem. Inst. Oswaldo Cruz. 82:1987;17-23.
16. Njenga M.N.et al. Peri-portal fibrosis of the liver due to natural or experimental infection with Schistosoma mansoni occurs in the Kenyan baboon. Ann. Trop. Med. Parasitol. 92:1998;187-193.
17. Warren K.S. The pathogenesis of 'clay-pipe stem cirrhosis' in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am. J. Pathol. 49:1966;477-489.
18. Cheever A.et al. Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 37:1987;85-97.
19. Wyler D.J., Talebian P. A quantitative assay to detect circulating fibrosin and its application in experimental schistosomiasis. Am. J. Trop. Med. Hyg. 56:1997;66-70.
20. Damian R.T.et al. Schistosoma mansoni in baboons, III. The course and characteristics of infection, with additional observations on immunity. Am. J. Trop. Med. Hyg. 25:1976;299-306.
21. Mutapi F.et al. Chemotherapy accelerates the development of acquired immune responses to Schistosoma mansoni infection. J. Infect. Dis. 178:1998;289-293.
22. Warren K.S., Domingo E.O. Granuloma formation around Schistosoma mansoni, S. haematobium and S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am. J. Trop. Med. Hyg. 19:1970;292-304.
23. Wynn T.A., Cheever A.W. Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol. 7:1995;505-511.
24. Sturrock R.F.et al. Schistosoma mansoni in the Kenyan baboon (Papio anubis): the development and predictability of resistance to homologous challenge. Trans. R. Soc. Trop. Med. Hyg. 72:1978;251-261.
25. Damian R.T., Greene N.D., Fitzgerald K. Schistosoma mansoni in baboons. II. Acquisition of immunity to challenge infection after repeated small exposures to cercariae of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 23:1974;78-80.
26. Wilson R.A. Leaky livers, portal shunting and immunity to schistosomes. Parasitol. Today. 6:1990;354-358.
27. Sturrock R.F.et al. Observations on the implications of pathology induced by experimental schistosomiasis in baboons in evaluating the development of resistance to challenge infection. Parasitology. 96:1988;37-48.
28. Suzuki T., Damian R.T. Schistosoma mansoni in baboons. IV. Development of antibodies to Schistosoma mansoni adult worm, egg, and cercarial antigens during acute and chronic infections. Am. J. Trop. Med. Hyg. 30:1981;825-835.
29. Smithers S.R., Terry R.J. Immunity in schistosomiasis. Ann. New York Acad. Sci. 160:1969;826-840.
30. Hagan P., Wikins H.A. Concomitant immunity. Parasitol. Today. 9:1993;3-6.
31. Terry R.J. Human immunity to schistosomiasis: concomitant immunity? Parasitol. Today. 10:1994;377-380.
32. Nyindo M.et al. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect. Immun. 67:1999;636-642.
33. Caulada-Benedetti Z.et al. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J. Immunol. 146:1991;1655-1660.
34. Coulson P.S. The radiation-attenuated vaccine against schistosomes in animal models: paradigms for a human vaccine? Adv. Parasitol. 39:1997;272-336.
35. Stek M. Jr.et al. Immunization of baboons with Schistosoma mansoni cercariae attenuated by gamma radiation. Science. 212:1981;1518-1520.
36. Nyindo M.et al. Schistosoma mansoni in the baboon: modulation of pathology after vaccination with polyclonal anti-idiotypic antibodies. Scand. J. Immunol. 42:1995;637-643.
37. Mangold B.I.et al. Site requirements and kinetics of immune dependent elimination of intravascularly administered lung stage schistosomula of mice immunised with highly irradiated cercariae of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 35:1986;332-344.
38. Smythies L., Coulson P.S., Wilson R.A. Immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae: cytokine interactions in the pulmonary protective response. Ann. Trop. Med. Parasitol. 87:1993;653-657.
39. Farah I.O., Nyindo M. Schistosoma mansoni induces in the Kenyan baboon a novel intestinal pathology that is manifestly modulated by an irradiated cercarial vaccine. J. Parasitol. 82:1996;601-607.
40. Butterworth A.et al. Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity. Biochimie. 70:1988;1053-1063.
41. Hagan P.et al. Human IgE, IgG4 and resistance to re-infection with Schistosoma haematobium. Nature. 349:1991;243-245.
42. Soisson L.A.et al. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent. J. Immunol. 151:1993;4782-4789.
43. Boulanger D.et al. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 13:1991;473-490.
44. Webbe G.J., James C., Nelson G.S. Schistosoma haematobium in the baboon (Papio anubis). Ann. Trop. Med. Parasitol. 68:1974;187-203.
45. Cheever A.W. Schistosoma haematobium: the pathology of experimental infection. Exp. Parasitol. 59:1985;131-138.
46. Reid G.D.F.et al. Schistosoma haematobium in the baboon (Papio anubis): assessment of protection levels against either a mass challenge or repeated trickle challenges after vaccination with irradiated schistosomula. J. Helminthol. 69:1995;139-147.
47. Cheever A.W. Schistosoma japonicum: the pathology of experimental infection. Exp. Parasitol. 59:1985;1-11.
48. Waine G.J., McManus D.P. Schistosomiasis vaccine development the current picture. BioEssays. 19:1997;435-443.